ChiCTR1900025771尚未招募Unknown
Crowdsourcing to Promote Hepatitis C Testing and Linkage-to-care in China: a Randomized Controlled Trial Protocol
Conquering Hepatitis via Micro-Elimination (CHIME) grant (ref no: IN-CN-987-5376)1 个研究点 分布在 1 个国家目标入组 1,006 人开始时间: 2019年9月2日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,006
- 试验地点
- 1
- 主要终点
- Number of HCV antibody screening test uptake
研究概览
简要总结
Specific aim 1: To compare the effects of a crowdsourcing intervention to the control on HCV test uptake among patients attending the primary care department in a tertiary hospital in China. Hypothesis 1: A crowdsourced intervention will be superior to the control in promoting HCV test uptake among patients attending the primary care department in a tertiary hospital in China.
研究设计
- 研究类型
- Interventional
- 主要目的
- 随机平行对照
- 盲法
- None
入排标准
- 年龄范围
- 30 至 100（—）
- 性别
- All
入选标准
- •Participants will be invited to participate if they are 30 years old or older, a Chinese, and will reside in Shenzhen for the following month.
排除标准
- •Participants will be excluded if they self-report one of the followings: known chronic HCV infection, testing for serum anti-HCV in the past 12 months, current or planned pregnancy, currently undergoing complex medical treatment for other conditions.
研究组 & 干预措施
Group 2
Crowd-sourcing contest materials to increase HCV uptake
Group 1
Standard of care on HCV testing uptake
结局指标
主要结局
Number of HCV antibody screening test uptake
次要结局
- Number of participants that additionally self-report HBsAg testing with/without confirmation by medical records or HBsAg viral load confirmatory testing
- Rate of participation in the crowdsourcing intervention
- Content of feedback submissions
- Number of participants that self-report HCV antibody testing but are not confirmed by medical records
- Number of participants that enrol in VCT service at HKU-SZH
- Number of participants that follow-up for HCV confirmatory testing
- Number of participants that join the peer training program at HKU-SZH
- Number of HCV diagnosed participants to continue with anti-HCV treatment, versus those who decline treatment for any reason
- Number of participants that will be completely cured of HCV infection, versus number that drop out prior to completing treatment
- Number of participants diagnosed with chronic liver disease (including cirrhosis, liver failure, or hepatocellular carcinoma)
- Number of participants that will return to primary care for chronic liver disease follow-up or future screening of HCV and other conditions
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex TraffickingNCT07264582Columbia University368
Unknown
不适用
HCV 自检促进中国男男性行为人群 HCV 检测的效果研究：两项平行随机对照试验ChiCTR2100048379政府60
尚未招募
不适用
Rate of Hepatitis C virus in blood donors by ABO blood group at JNMC, sawangi, wardhaCTRI/2024/07/071140Datta Meghe Institute of Higher Education Research5,000
进行中（未招募）
不适用
SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOFNCT07316842Center of target therapy30
尚未招募
不适用
A patient survey on liver cancer surveillance practices in IndiaCTRI/2024/09/073208Tata Memorial Hospital500